. Energy and macronutrient intake among participants completing the study, assessed using 4-day mobile food records (mFR™) captured by participants in the IER+MED group and DASH group over three time points 1 IER+MED 11.6 ± 0.5 11.1± 0.6 0.563 11.7 ± 0.6 0.830 IER 11.2± 0.7 11.4 ± 0.6 MED 10.9 ± 0.7 11.6 ± 0.8 DASH 11.6 ± 0.5 10.8 ± 0.4 0.103 11.8 ± 0.5 0.789 Monounsaturated fatty acids (% energy) IER+MED 13.5 ± 0.4 15.0 ± 0.7 0.065 16.0 ± 0.7 0.001 IER 16.4 ± 1.0 17.2 ± 0.9 MED 14.3 ± 0.7 16.9 ± 1.5 DASH 14.4 ± 0.5 13.3 ± 0.5 0.081 13.7 ± 0.6 0.289 Polyunsaturated fatty acids (% energy) IER+MED 8.2 ± 0.6 9.5 ± 0.6 0.104 8.7 ± 0.5 0.470 IER 12.0 ± 1.3 9.8 ± 0.8 MED 8.8 ± 0.6 8.5 ± 0.7 DASH 9.1 ± 0.6 9.2 ± 0.6 0.859 7.8 ± 0.5 0.120 Dietary fiber (g) IER+MED 13.0 ± 1.2 12.7 ± 1.0 0.799 11.7 ± 1.0 0.256 IER 10.5 ± 0.9 9.3 ± 0.8 MED 13.3 ± 1.1 12.8 ± 1.2 DASH 13.5 ± 1.1 14.8 ± 1.3 0.420 14.3 ± 0.9 0.473 Data are presented as mean/day ± standard error of the mean (SEM). IER+MED: Intermittent energy restriction combined with a Mediterranean diet. DASH: Dietary Approaches to Stop Hypertension diet. 1 All data analyzed using a repeated measures mixed model for only the 54 participants who completed the study. 2 Within group difference from baseline to Weeks 5-6. 3 Within group difference from baseline to Week 11. 4 Weighted for five Mediterranean diet (MED) days and two intermittent energy restriction (IER) days. 5 IER days assessed using two days of 4-day mFR™. 6 MED days assessed using two days of 4-day mFR™. IER+MED 62 ± 9 81 ± 9 74 ± 8 IER 81 ± 9 72 ± 8 MED 79 ± 9 76 ± 9 DASH 60 ± 7 60 ± 6 58 ± 5 Thiamin (mg) IER+MED 1.3 ± 0.1 1.0 ± 0.1 0.9 ± 0.1 IER 0.8 ± 0.1 0.7 ± 0.1 MED 1.0 ± 0.1 0.9 ± 0.1 DASH 1.3 ± 0.1 1.1 ± 0.1 1.3 ± 0.1 Riboflavin (mg) IER+MED 1.5 ± 0.1 1.5 ± 0.1 1.4 ± 0.1 IER 1.3 ± 0.1 1.3 ± 0.1 MED 1.5 ± 0.1 1.4 ± 0.1 DASH 1.7 ± 0.2 1.5 ± 0.2 1.7 ± 0.1 Niacin (mg) IER+MED 19 ± 1 18 ± 1 17 ± 1 IER 16 ± 1 15 ± 1 MED 18 ± 1 17 ± 1 DASH 22 ± 2 17 ± 1 19 ± 1 Vitamin B6 (mg) IER+MED 1.5 ± 0.1 1.6 ± 0.1 1.5 ± 0.1 IER 1.4 ± 0.1 1.2 ± 0.1 MED 1.6 ± 0.1 1.5 ± 0.1 DASH 1.7 ± 0.2 1.5 ± 0.2 1.6 ± 0. IER+MED 107 ± 6 97 ± 9 90 ± 7 IER 83 ± 7 87 ± 7 MED 99 ± 9 91 ± 7 DASH 111 ± 7 94 ± 7 102 ± 5 Zinc (mg) IER+MED 9.8 ± 0.6 8.5 ± 0.6 8.3 ± 0.5 IER 7.1 ± 0.5 6.9 ± 0.4 MED 8.8 ± 0.6 8.9 ± 0.6 DASH 10.3 ± 0.8 8.8 ± 0.8 9.9 ± 0.8 Data are presented as mean/day ± standard error of the mean (SEM). IER+MED: Intermittent energy restriction combined with a Mediterranean diet. DASH: Dietary Approaches to Stop Hypertension diet. 1 Analyzed using data from participants at baseline (IER+MED, n=30; DASH, n=30) , and participants remaining in the study at Weeks 5-6 (IER+MED, n=26; DASH, n=30), and Week 11 (IER+MED, n=26; DASH, n=28). 2 Weighted for five Mediterranean diet (MED) days and two intermittent energy restriction (IER) days. 3 IER days assessed using two days of 4-day mFR. 4 MED days assessed using two days of 4-day mFR. Table S3 . Proportion of participants meeting US EAR for vitamin and mineral intake, assessed using 4-day mobile food records (mFR™) captured by participants in the IER+MED group and DASH group over three time points 1 .
Baseline
Weeks 5-6 Week 11
Calcium ( Settings and locations where the data were collected 2,3,6,7 4c
How participants were identified and consented 3 Interventions 5
The interventions for each group with sufficient details to allow replication, including how and when they were actually administered
5,6
Outcomes 6a Completely defined prespecified assessments or measurements to address each pilot trial objective specified in 2b, including how and when they were assessed 3,5,6,7 
